Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-17

Clinical Trial Update: Bendamustine and Radiation Therapy in Treating Patients With Brain Metastases Caused by Solid Tumors [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated bendamustine in combination with radiation therapy to treat brain metastases from solid tumors and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bendamustine (Bendamustine)

Snippet

Sponsor: John Grecula | Conditions: Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Status: COMPLETED